This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the activities for this article:
Sports Test 2: Diagnosis and Treatment
Sports Test 1: The Knee
Adult Knee Reconstruction Test 3: Arthroscopy, Osteotomy, Medical Therapies
Right arrow Letters to the Editor: Submit a response
Right arrow Letters to the Editor: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leopold, S. S
Right arrow Articles by Shott, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leopold, S. S
Right arrow Articles by Shott, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 85:1197-1203 (2003)
© 2003 The Journal of Bone and Joint Surgery, Inc.


Scientific Article

Corticosteroid Compared with Hyaluronic Acid Injections for the Treatment of Osteoarthritis of the Knee

A Prospective, Randomized Trial

Seth S Leopold, MD, Brigham B Redd, MD, Winston J Warme, MD, Paul A Wehrle, MD, Patrick D Pettis, LVN and Susan Shott, PhD

Investigation performed at the Orthopaedic Surgery Service, William Beaumont Army Medical Center, El Paso, Texas, and the Department of Orthopaedics and Sports Medicine, University of Washington Medical Center, Seattle, Washington

Seth S. Leopold, MD
Department of Orthopaedics and Sports Medicine, University of Washington Medical Center, 1959 N.E. Pacific Street, Box 356500, Seattle, WA 98195. E-mail address: leopold{at}u.washington.edu

Brigham B. Redd, MD
Winston J. Warme, MD
Patrick D. Pettis, LVN
Orthopaedic Surgery Service (B.B.R., W.J.W., and P.D.P.) and Rheumatology Service (P.A.W.), William Beaumont Army Medical Center, 5005 North Piedras Street, El Paso, TX 79920

Paul A. Wehrle, MD
Rheumatology Service, Walter Reed Army Medical Center, 6900 Georgia Avenue N.W., Washington CD 20307

Susan Shott, PhD
Biostatistics Unit (OB-GYN), Rush-Presbyterian-St. Luke's Medical Center, 1653 West Congress Parkway, Chicago, IL 60612

In support of their research or preparation of this manuscript, one or more of the authors received grants or outside funding from William Beaumont Army Medical Center, Department of Clinical Investigation (WBAMC Grant 00/22). None of the authors received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

The views expressed in this paper are those of the authors and do not reflect the official policy of the Department of Defense or the United States Government.

Background: Although both corticosteroid and hyaluronic acid injections are widely used to palliate the symptoms of knee osteoarthritis, little research involving a comparison of the two interventions has been done. We tested the hypothesis that there are no significant differences between Hylan G-F 20 (Synvisc) and the corticosteroid betamethasone sodium phosphate-betamethasone acetate (Celestone Soluspan) in terms of pain relief or improvement in function, as determined by validated scoring instruments.

Methods: One hundred patients with knee osteoarthritis were randomized to receive intra-articular injection of either Hylan G-F 20 or the corticosteroid, and they were followed for six months. The patients treated with Hylan G-F 20 received one course of three weekly injections. The patients treated with the corticosteroid received one injection at the time of enrollment in the study, and they could request one more injection any time during the study. An independent, blinded evaluator assessed the patients with the Western Ontario and McMaster University Osteoarthritis Index (WOMAC), a modification of the Knee Society rating system, and the visual analog pain scale.

Results: Both the group treated with the corticosteroid and the group treated with Hylan G-F 20 demonstrated improvements from baseline WOMAC scores (a median decrease from 55 to 40 points and from 54 to 44 points, respectively; p < 0.01 for both). The scores according to the Knee Society system did not significantly improve for the patients who received the corticosteroid (median, 58 to 70 points; p = 0.06) or for those who received Hylan G-F 20 (median, 58 to 68 points; p = 0.15). The scores on the visual analog scale improved for patients receiving Hylan G-F 20 (median, 70 to 52 mm; p < 0.01) but not for the patients who received the corticosteroid (median, 64 to 52 mm; p = 0.28). However, no significant differences between the two treatment groups were found with respect to the WOMAC, Knee Society system, or visual analog scale results. Women demonstrated a significant improvement in only one of the six possible outcome-treatment combinations (the WOMAC scale), whereas men demonstrated significant improvements in five of the six outcomes (all measures except the Knee Society rating system).

Conclusions: No differences were detected between patients treated with intra-articular injections of Hylan G-F 20 and those treated with the corticosteroid with respect to pain relief or function at six months of follow-up. Women demonstrated significantly less response to treatment than men did for both treatments on all three outcome scales. Such significant gender-related differences warrant further investigation.

Level of Evidence: Therapeutic study, Level I-1b (randomized controlled trial [no significant difference but narrow confidence intervals]). See Instructions to Authors for a complete description of levels of evidence.




Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Evid. Based Med.Home page
S. Shoor
Review: viscosupplementation for knee osteoarthritis reduces pain and improves function
Evid. Based Med., February 1, 2006; 11(1): 12 - 12.
[Full Text] [PDF]


Home page
ptjournalHome page
G. D Deyle, S. C Allison, R. L Matekel, M. G Ryder, J. M Stang, D. D Gohdes, J. P Hutton, N. E Henderson, and M. B Garber
Physical Therapy Treatment Effectiveness for Osteoarthritis of the Knee: A Randomized Comparison of Supervised Clinical Exercise and Manual Therapy Procedures Versus a Home Exercise Program
Physical Therapy, December 1, 2005; 85(12): 1301 - 1317.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. D. Miller
What's New in Sports Medicine
J. Bone Joint Surg. Am., March 1, 2004; 86(3): 653 - 661.
[Full Text] [PDF]


Home page
JBJSHome page
A. H. Morton, P. Shannon, A. L. Chen, P. E. Di Cesare, E. M. Adler, P. Desai, S. S. Leopold, W. J. Warme, P. D. Pettis, and S. Shott
Increased Frequency of Acute Local Reaction to Intra-Articular Hylan G-F 20 (Synvisc) in Patients Receiving More Than One Course of Treatment
J. Bone Joint Surg. Am., October 1, 2003; 85(10): 2050 - 2051.
[Full Text]


Home page
JWatch GeneralHome page
Intra-articular Hyaluronic Acid vs. Steroids for Knee Osteoarthritis
Journal Watch (General), July 29, 2003; 2003(729): 5 - 5.
[Full Text]

Letters to the Editor:

Read all Letters to the Editor

Corticosteroid Compared with Hyaluronic Acid Injections of the Knee
Charalambos P Charalambous
JBJS Online, 15 Oct 2003 [Full text]
Dr. Leopold responds to Dr. Charalambous
Seth S. Leopold, et al.
JBJS Online, 20 Oct 2003 [Full text]